CalbaTech Announces $999,926 Reduction in Debt; First Adult Stem Cell Harvesting... ( LAGUNA HILLS Calif. March 31 /- C...)

CalbaTech Announces $999,926 Reduction in Debt; First Adult Stem Cell Harvesting Scheduled

Date:3/31/2008

LAGUNA HILLS, Calif., March 31 /PRNewswire-FirstCall/ -- CalbaTech, Inc. (OTC Bulletin Board: CLBE), the emerging life sciences company (http://www.CalbaTech.com ) concentrating on the collection and banking of adult stem cells for possible future therapeutic uses, today announced the Company decreased debt by $999,926 in 2007.

CalbaTech announced revenues of $1.149 million in 2007, down slightly from $1.250 million in 2006. Gross profit in 2007 totaled $662,849. Net income in 2007 was $27,940 compared to $13,801 in 2006.

"The significant decrease in debt is a major achievement for our financial stability and our future prospects," said James DeOlden, CEO. "We are also pleased to announce that the very first harvesting of adult stem cells by LifeStem(TM) will occur at the Youthtopia Med Spa, near Atlanta, on May 10th."

Mr. DeOlden also announced that "Keller Medical Institute, the well respected medical group headquartered in Monterey, California, which is marketing and selling the LifeStem(TM) service for the collection of healthy adult stem cells for future medical use, has added three physicians to its LifeStem training program."

LifeStem(TM) is a wholly owned subsidiary of CalbaTech. The procedure it developed for the harvesting of adult stem cells uniquely involves the collection of both blood and adipose tissue. The process allows for the collection of adult stem cells in micro quantities to be cryopreserved for future transplantation into the same client, with possible future medical therapies ranging from heart disease to diabetes and other diseases that are currently difficult to treat.

About CalbaTech

CalbaTech, Inc. (OTC Bulletin Board: CLBE) is the emerging life sciences company (http://www.CalbaTech.com), concentrating on providing products and platforms to the research market for biotech and pharmace
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. CalbaTech Reports That LifeStems Biologics License Has Been Renewed
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)

Post Your Comments:

CalbaTech Announces $999,926 Reduction in Debt; First Adult Stem Cell Harvesting...( LAGUNA HILLS Calif. March 31 /- C...),Health